annual CFI:
$75.65M-$16.40M(-17.81%)Summary
- As of today (September 18, 2025), AMLX annual cash flow from investing activities is $75.65 million, with the most recent change of -$16.40 million (-17.81%) on December 31, 2024.
- During the last 3 years, AMLX annual CFI has risen by +$122.06 million (+263.03%).
- AMLX annual CFI is now -17.81% below its all-time high of $92.05 million, reached on December 31, 2023.
Performance
AMLX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$22.99M+$66.65M(+152.67%)Summary
- As of today (September 18, 2025), AMLX quarterly cash flow from investing activities is $22.99 million, with the most recent change of +$66.65 million (+152.67%) on June 1, 2025.
- Over the past year, AMLX quarterly CFI has increased by +$51.95 million (+179.40%).
- AMLX quarterly CFI is now -81.34% below its all-time high of $123.22 million, reached on June 30, 2023.
Performance
AMLX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$83.13M+$51.95M(+166.65%)Summary
- As of today (September 18, 2025), AMLX TTM cash flow from investing activities is $83.13 million, with the most recent change of +$51.95 million (+166.65%) on June 1, 2025.
- Over the past year, AMLX TTM CFI has increased by +$198.44 million (+172.10%).
- AMLX TTM CFI is now -9.69% below its all-time high of $92.05 million, reached on December 31, 2023.
Performance
AMLX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AMLX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.8% | +179.4% | +172.1% |
| 3 y3 years | +263.0% | +415.3% | +187.7% |
| 5 y5 years | +100.0% | - | - |
AMLX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.8% | +131.7% | -81.3% | +110.1% | -9.7% | +134.8% |
| 5 y | 5-year | -17.8% | +131.7% | -81.3% | +110.1% | -9.7% | +134.8% |
| alltime | all time | -17.8% | +131.7% | -81.3% | +110.1% | -9.7% | +134.8% |
AMLX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $22.99M(-152.7%) | $83.13M(+166.7%) |
| Mar 2025 | - | -$43.66M(-167.2%) | $31.18M(-58.8%) |
| Dec 2024 | $75.65M(-17.8%) | $64.98M(+67.4%) | $75.65M(+139.4%) |
| Sep 2024 | - | $38.82M(-234.0%) | $31.60M(-127.4%) |
| Jun 2024 | - | -$28.96M(-3636.1%) | -$115.31M(-412.7%) |
| Mar 2024 | - | $819.00K(-96.1%) | $36.88M(-59.9%) |
| Dec 2023 | $92.05M | $20.93M(-119.4%) | $92.05M(-158.6%) |
| Sep 2023 | - | -$108.09M(-187.7%) | -$157.05M(-547.7%) |
| Jun 2023 | - | $123.22M(+120.1%) | $35.08M(-141.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $55.99M(-124.5%) | -$83.68M(-65.0%) |
| Dec 2022 | -$238.99M(+415.0%) | -$228.18M(-371.5%) | -$238.99M(+2111.2%) |
| Sep 2022 | - | $84.04M(+1783.5%) | -$10.81M(-88.6%) |
| Jun 2022 | - | $4.46M(-104.5%) | -$94.85M(-4.5%) |
| Mar 2022 | - | -$99.31M(<-9900.0%) | -$99.31M(>+9900.0%) |
| Dec 2021 | -$46.41M(>+9900.0%) | - | - |
| Jun 2021 | - | $0.00(-100.0%) | -$14.00K(0.0%) |
| Mar 2021 | - | -$14.00K | -$14.00K |
| Dec 2020 | -$151.00K(<-9900.0%) | - | - |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Amylyx Pharmaceuticals, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. annual CFI year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. quarterly CFI year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. TTM CFI year-on-year change?
What is Amylyx Pharmaceuticals, Inc. annual cash flow from investing activities?
The current annual CFI of AMLX is $75.65M
What is the all time high annual CFI for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high annual cash flow from investing activities is $92.05M
What is Amylyx Pharmaceuticals, Inc. annual CFI year-on-year change?
Over the past year, AMLX annual cash flow from investing activities has changed by -$16.40M (-17.81%)
What is Amylyx Pharmaceuticals, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of AMLX is $22.99M
What is the all time high quarterly CFI for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high quarterly cash flow from investing activities is $123.22M
What is Amylyx Pharmaceuticals, Inc. quarterly CFI year-on-year change?
Over the past year, AMLX quarterly cash flow from investing activities has changed by +$51.95M (+179.40%)
What is Amylyx Pharmaceuticals, Inc. TTM cash flow from investing activities?
The current TTM CFI of AMLX is $83.13M
What is the all time high TTM CFI for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high TTM cash flow from investing activities is $92.05M
What is Amylyx Pharmaceuticals, Inc. TTM CFI year-on-year change?
Over the past year, AMLX TTM cash flow from investing activities has changed by +$198.44M (+172.10%)